American Well (AMWL)
(Delayed Data from NYSE)
$0.51 USD
0.00 (-0.27%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $0.52 +0.01 (1.19%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
American Well Corporation (AMWL) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$2.04 | $4.00 | $1.00 | 292.31% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for American Well Corporation comes to $2.04. The forecasts range from a low of $1.00 to a high of $4.00. The average price target represents an increase of 292.31% from the last closing price of $0.52.
Analyst Price Targets (7 )
Broker Rating
American Well Corporation currently has an average brokerage recommendation (ABR) of 2.56 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 2.56 a month ago based on nine recommendations.
Of the nine recommendations deriving the current ABR, two are Strong Buy, representing 22.22% of all recommendations. A month ago, Strong Buy represented 22.22%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 7 | 7 | 7 | 7 | 7 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.56 | 2.56 | 2.56 | 2.56 | 2.56 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/4/2024 | Piper Sandler | Jessica E Tassan | Hold | Hold |
3/4/2024 | Truist Securities | Jailendra Singh | Hold | Hold |
1/2/2024 | BTIG | David M Larsen | Not Available | Hold |
11/9/2023 | Guggenheim Securities | Jack D Wallace | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.56 |
ABR (Last week) | 2.56 |
# of Recs in ABR | 9 |
Average Target Price | $2.04 |
LT Growth Rate | 36.80% |
Industry | Medical Info Systems |
Industry Rank by ABR | 149 of 252 |
Current Quarter EPS Est: | -0.18 |